Replies to post #134562 on Biotech Values

[mcbio]

who's next on the HCV uber premium buyout gravy train? ACHN ,IDIX , FURX ?

What does FURX have in HCV?

i see Medivir has a phase3 in HCV, J&J partner i believe?

Though I really like Medivir, I doubt they'll be a buyout candidate given that they're already partnered with JNJ/Tibotec on TMC435 and their pre-clinical nuke.

[jbog]

I don't think Vertex will stay independent forever, but they won't have a so called 'ubber premium'.

[NP1986]

Don't forget PPHM. LOL.